itinai content

  • AI News
  • AI Sales
  • Apple AI
  • Biohacking
  • Clinical Trials
  • Compare
  • Computer Vision
  • DeepSense
  • farma
  • Instruments
  • Management
  • Marketing
  • Marktechpost
  • Open AI
  • resume
  • КП
  • Investigation of the Relevance of CYP3A4 Inhibition on the Pharmacokinetics of the Novel P2X3 Antagonist Filapixant: Results of In Vitro Explorations and a Fixed-Sequence Clinical Trial with Itraconazole in Healthy Volunteers

    29 октября, 2025

    Hypersensitized P2X3 receptor signaling has been described to play a role in several disorders, including chronic cough. The goal of our in vitro and in vivo studies was to investigate the biotransformation and the influence of CYP3A4 inhibition on the pharmacokinetics of the selective P2X3 antagonist filapixant. Metabolic turnover of filapixant in human liver microsomes… →

    Clinical Trials
  • Why your sales enablement content needs real-world credibility [new data]

    29 октября, 2025

    I spent three years creating product-led blog posts and case studies for B2B SaaS companies before I realized something obvious: sales enablement content credibility determines whether reps will actually use what you create. When a rep shared my article in a prospect conversation or referenced a customer story during a demo, that content became part… →

    AI Sales
    AI, Analytics, B2BMarketing, B2BSales, BrandStrategy, ContentMarketing, ConversionOptimization, CustomerExperience, DataDriven, DigitalMarketing, Ecommerce, GrowthHacking, InboundMarketing, LeadGeneration, MarketingAutomation, MarketingTips, Salesforce, SEO, SocialSelling, TechnologyTrends
  • The establishment and application of an early warning scoring system for neonatal pneumonia based on information technology

    29 октября, 2025

    CONCLUSION: The application of an early warning scoring system for neonatal pneumonia based on information technology can shorten the time to symptom resolution, improve respiratory status, normalize blood gas indices, and reduce the incidence of complications. →

    Clinical Trials
  • Liquid AI Releases LFM2-ColBERT-350M: A New Small Model that brings Late Interaction Retrieval to Multilingual and Cross-Lingual RAG

    29 октября, 2025

    Liquid AI Releases LFM2-ColBERT-350M: A New Small Model that Brings Late Interaction Retrieval to Multilingual and Cross-Lingual RAG Target Audience Analysis The target audience for the LFM2-ColBERT-350M model primarily includes data scientists, AI researchers, and business managers in tech companies focused on natural language processing (NLP) and information retrieval. These professionals are often tasked with… →

    AI News
  • The Three Obstacles Slowing Responsible AI

    29 октября, 2025

    Anna & Elena Balbusso/theispot.com In October 2023, New York City released its AI action plan, publicly committing to the responsible and transparent use of artificial intelligence. The plan included guiding principles — accountability, fairness, transparency — and the creation of a new role to oversee their responsible implementation: the algorithm management and policy officer. But… →

    Management
  • Personalization and Innovation in a Regulated Industry: Experian’s Kathleen Peters

    29 октября, 2025

    Kathleen Peters brings a background with digital communications companies and tech startups to her role as Experian’s chief innovation officer. On this episode of the Me, Myself, and AI podcast, Kathleen shares a bit about Experian’s Innovation Lab, outlining some of its projects and explaining how the recent democratization of generative AI tools has made… →

    Management
  • Effect of Valemetostat on the Pharmacokinetics of Midazolam and Digoxin: A Phase 1 Drug-Drug Interaction Study in Patients With Non-Hodgkin Lymphoma

    29 октября, 2025

    Valemetostat tosylate (valemetostat) is an oral, potent, dual inhibitor of enhancer of zeste homolog (EZH)2/1, under investigation in non-Hodgkin lymphomas (NHLs) and solid tumors. In vitro, it inhibits cytochrome P450 3A (CYP3A) and P-glycoprotein (P-gp) when combined with sensitive CYP3A or P-gp substrates. This drug-drug interaction (DDI) sub-study is part of the phase 1 trial… →

    Clinical Trials
  • Computational Modelling Suggests Bacteriostatic Saline Does Not Reverse Botulinum Toxin-Induced Brow Ptosis

    29 октября, 2025

    Anecdotal reports have recently circulated suggesting that intramuscular injection of bacteriostatic saline (BS)-which contains benzyl alcohol (BnOH)-can reverse botulinum toxin type A (BoNTA)-induced brow ptosis. Given the well-established intracellular persistence of BoNTA’s light chain and its irreversible cleavage of SNAP-25, such rapid functional recovery challenges existing pharmacological understanding. This study employed high-resolution pharmacokinetic/pharmacodynamic (PK/PD) modelling… →

    Clinical Trials
  • Cost-effectiveness of office-based, magnetic resonance imaging-guided transperineal versus transrectal prostate biopsy: An economic analysis of the PREVENT trial

    29 октября, 2025

    CONCLUSIONS: In this model, TP biopsy was more cost-effective than TR from a health care payer perspective. In the setting of increasing concerns about the risk of infection from traditional TR biopsy, these findings suggest that office-based TP biopsy is a more cost-effective population-level alternative. →

    Clinical Trials
  • How Exploration Agents like Q-Learning, UCB, and MCTS Collaboratively Learn Intelligent Problem-Solving Strategies in Dynamic Grid Environments

    29 октября, 2025

    «`html How Exploration Agents like Q-Learning, UCB, and MCTS Collaboratively Learn Intelligent Problem-Solving Strategies in Dynamic Grid Environments Understanding the Target Audience The target audience for this tutorial includes data scientists, machine learning engineers, and business analysts interested in applying reinforcement learning techniques to solve complex problems. These individuals typically work in technology-driven industries and… →

    AI News
Предыдущая страница
1 … 17 18 19 20 21 … 848
Следующая страница